InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Woodrow Adam, Chief Executive Officer. Officer active across 1 company, notably Paratek Pharmaceuticals, Inc.. Aggregated, 12 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €48k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 8 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Woodrow Adam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
622,284 sharesCommon StockSEC:0000899243-23-019354:0
98,750 shares0Common StockSEC:0000904454-23-000480:0
22,500 shares0Common StockSEC:0000904454-22-000655:0
3,820 shares@ US$1.989.8% of flowCommon StockSEC:0000904454-22-000629:0
4,563 shares@ US$3.4721.7% of flowCommon StockSEC:0000904454-22-000534:0
15,000 shares0Common StockSEC:0000904454-22-000512:0
71,591 shares0Common StockSEC:0000904454-22-000431:0
101,250 shares0Common StockSEC:0000904454-22-000270:0
6,422 shares@ US$4.4252.1% of flowCommon StockSEC:0000904454-21-000838:0
37,500 shares0Common StockSEC:0000904454-21-000622:0
42,955 shares0Common StockSEC:0000904454-21-000520:0
25,000 sharesCommon StockSEC:0000904454-16-000918:0
12 of 12 declarations
About Woodrow Adam
Woodrow Adam is Directeur Général and President & Chief Commercial at Paratek Pharmaceuticals, Inc. He has reported 12 filings in total, and across the 12 sampled filings between 2016-02-08 and 2023-09-21, the reported sell amount is EUR 48166, with the modal transaction nature shown as Attribution.
